July 14, 2020Open Access

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The proper understanding of NAFLD spectrum-as a continuum from obesity to metabolic syndrome and diabetes-may contribute to the early identification and for establishment of targeted treatment.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Godoy‐Matos et al. (Tue,) studied this question.

synapsesocial.com/papers/69dff16487e00d00cde9be8d https://doi.org/https://doi.org/10.1186/s13098-020-00570-y

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin2013 · 18 citations
2Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content2008 · 74 citations
3Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery2014 · 115 citations
4Efeito da perda ponderal induzida pela cirurgia bariátrica sobre a prevalência de síndrome metabólica2009 · 25 citations
5Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies2012 · 390 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo